Skip to main content

Generic semaglutide update: 3 of 9 generic semaglutide products approved by Health Canada. See timeline →

Does Manitoba Pharmacare cover Ozempic or Mounjaro?

By GLP1Prices Editorial · Plan rules checked November 14, 2026 · Sources under each section

Is Ozempic, Wegovy, Mounjaro or Zepbound covered by Manitoba Pharmacare?

Manitoba Pharmacare is the province's drug benefit program: coverage depends on your family income, and each year you pay a deductible before it pays. It covers the drugs on the Manitoba Drug Benefits Formulary and, once approved, Exception Drug Status (EDS) drugs. Its answer for each drug:

Sources: Manitoba: About the Manitoba Pharmacare Program (read November 14, 2026); Manitoba Drug Benefits and Interchangeability Formulary (editions effective November 1, 2026) (read November 14, 2026); Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026)

The short answer

Manitoba Pharmacare pays for Ozempic and generic semaglutide only through Exception Drug Status (EDS): your prescriber applies, Manitoba approves the request under the criteria on its EDS list, and the plan pays after your yearly deductible. Mounjaro, Zepbound and Wegovy are not Part 1 or Part 2 benefits and are not on the EDS list. None of them is on the no-cost Manitoba Enhanced Pharmacare Program list either. Without coverage you pay the pharmacy's price: the lowest prices we list in Manitoba are below.

Sources: Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026); Manitoba Drug Formulary Lookup: searches for Ozempic, semaglutide, Mounjaro, tirzepatide, Wegovy, Zepbound, Rybelsus, Saxenda and liraglutide (read November 14, 2026); Manitoba Enhanced Pharmacare Program Drug List (dated November 1, 2026) (read November 14, 2026)

What you pay without coverage in Manitoba

If a drug is not a Pharmacare benefit, or its EDS request is not approved, you pay for it unless another plan does; for an approved EDS drug, you pay your deductible first. These are the lowest prices we list in Manitoba, with the pharmacy and the date the price was last updated.

Sources: Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026); Manitoba: About the Manitoba Pharmacare Program (read November 14, 2026)

DrugPublic plan statusLowest price we list in Manitoba
OzempicException Drug Status (EDS)$222 at Costco Pharmacy0.25mg/0.5mL pen, 1 pen · Updated November 20263 pharmacies listed
Generic semaglutide (Apo-Semaglutide)Exception Drug Status (EDS)No price listed yet
MounjaroNot on the Formulary or the EDS listNo price listed yet
WegovyNot on the Formulary or the EDS list$422 at Costco Pharmacy2.4mg pen, 1 pen · Updated November 20262 pharmacies listed
ZepboundNot on the Formulary or the EDS listNo price listed yet

Status from the plan's own lists (sources under each section below). Prices are the lowest active price we list per drug in Manitoba, before any plan or savings card; a pharmacy may add a dispensing fee.

How Manitoba Pharmacare decides what it pays

Manitoba Pharmacare is "a drug benefit program for eligible Manitobans" whose income is seriously affected by high prescription drug costs. Coverage is based on your total family income and on what you pay for eligible prescription drugs: each year you pay a portion, your annual Pharmacare deductible, which Pharmacare sets from your adjusted family income. You qualify if you are eligible for Manitoba Health coverage and your prescriptions are not covered by another provincial or federal program.

Source: Manitoba: About the Manitoba Pharmacare Program (read November 14, 2026)

The Manitoba Drug Benefits Formulary has two parts. Part 1 drugs are benefits "under all prescribed circumstances"; Part 2 drugs only for the terms and conditions the Formulary sets. When a drug is not in Part 1 or Part 2, "a request for coverage may be considered under Exception Drug Status (EDS)": the doctor applies, and you are told the decision in writing.

Source: Manitoba Drug Benefits and Interchangeability Formulary (editions effective November 1, 2026) (read November 14, 2026)

For an EDS drug, a practitioner sends the request by mail or fax. Approval "must take place prior to purchase or dispensing", and "Retroactive coverage is not provided". Manitoba sends you a letter saying whether the request was approved, and an approved drug is covered for the period EDS authorizes "and after the client's Pharmacare deductible has been met". Some EDS approvals are indefinite; semaglutide is not on that list, so a renewal request goes in before the approval expires.

Sources: Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026); Manitoba: List of Designated Drugs with Indefinite Exception Drug Status Approval (dated November 5, 2025) (read November 14, 2026)

Since April 15, 2025, the Manitoba Enhanced Pharmacare Program (MEPP) covers the medications on its drug list at no cost, with no Pharmacare deductible, for people with an active Manitoba Health card. No semaglutide or tirzepatide product is on that list. Manitoba's MEPP page says "Ozempic was not included in the federal list of medications for no-cost coverage for discussion with provinces and territories."

Sources: Manitoba Enhanced Pharmacare Program (MEPP) (read November 14, 2026); Manitoba Enhanced Pharmacare Program Drug List (dated November 1, 2026) (read November 14, 2026)

Ozempic and generic semaglutide in Manitoba

Status: Exception Drug Status (EDS)

Manitoba's Exception Drug Status list of November 1, 2026 includes the three Ozempic pens (DINs 02471469, 02471477 and 02540258), Apotex's Apo-Semaglutide Injection (DINs 02568020 and 02568012) and Dr. Reddy's Semaglutide Injection (DINs 02567806 and 02567814), with the criteria Manitoba publishes for them. The Drug Formulary Lookup finds none of them as a Part 1 or Part 2 benefit.

Sources: Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026); Manitoba Drug Formulary Lookup: searches for Ozempic, semaglutide, Mounjaro, tirzepatide, Wegovy, Zepbound, Rybelsus, Saxenda and liraglutide (read November 14, 2026)

Pharmacare pays for them only once an EDS request is approved, and the approval must come before the prescription is filled: there is no retroactive coverage, and if the request is denied, the patient pays. Coverage runs from the date of application to the expiry date, and semaglutide is not among the drugs with indefinite approval, so your prescriber sends a renewal request before it expires.

Sources: Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026); Manitoba: List of Designated Drugs with Indefinite Exception Drug Status Approval (dated November 5, 2025) (read November 14, 2026)

Ozempic and the generic pens are in the same interchangeable categories of the Manitoba Drug Interchangeability Formulary, and "Manitoba Pharmacare will reimburse only up to the lowest price in an interchangeable category for those interchangeable drugs which are Pharmacare benefits."

Sources: Manitoba Drug Interchangeability Formulary, 152nd edition, effective November 1, 2026 (read November 14, 2026); Manitoba Drug Benefits and Interchangeability Formulary (editions effective November 1, 2026) (read November 14, 2026)

Ozempic prices in Manitoba

Mounjaro in Manitoba

Status: Not on the Formulary or the EDS list

A Drug Formulary Lookup search for Mounjaro or tirzepatide returns "No results were found that matched your search criteria": it is not a Part 1 or Part 2 benefit. The EDS list of November 1, 2026 has no tirzepatide product, and the EDS list itself says "Not all medications currently available on the market in Canada are benefits" of the Formulary or the EDS program.

Sources: Manitoba Drug Formulary Lookup: searches for Ozempic, semaglutide, Mounjaro, tirzepatide, Wegovy, Zepbound, Rybelsus, Saxenda and liraglutide (read November 14, 2026); Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026)

Wegovy in Manitoba

Status: Not on the Formulary or the EDS list

The Drug Formulary Lookup finds no Wegovy, and the semaglutide products on the EDS list are Ozempic and the generic pens. If a request is not approved, Manitoba says, payment for the medication is the patient's responsibility.

Sources: Manitoba Drug Formulary Lookup: searches for Ozempic, semaglutide, Mounjaro, tirzepatide, Wegovy, Zepbound, Rybelsus, Saxenda and liraglutide (read November 14, 2026); Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026)

Wegovy prices in Manitoba

Zepbound in Manitoba

Status: Not on the Formulary or the EDS list

Zepbound is tirzepatide too. The Drug Formulary Lookup finds no Zepbound or tirzepatide, and the EDS list has no tirzepatide product.

Sources: Manitoba Drug Formulary Lookup: searches for Ozempic, semaglutide, Mounjaro, tirzepatide, Wegovy, Zepbound, Rybelsus, Saxenda and liraglutide (read November 14, 2026); Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026)

Private and workplace plans

An employer or other private plan sets its own rules. Manitoba's EDS list notes that some private and extended health insurers ask for the EDS approval before they pay any part of the prescription. Sun Life and Canada Life put Ozempic on prior authorization: your prescriber fills in part of the insurer's form, and the insurer pays only once it approves the request. Wegovy is covered only on plans that include it. Ask your insurer about Mounjaro and Zepbound, or check with the Coverage Checker.

Sources: Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026); Sun Life: Prior Authorization Form, OZEMPIC (semaglutide) or generic products, 4233-PA-OZE-E-09-26 (read November 14, 2026); Sun Life: report for plan sponsors on drug management strategies (November 2025) (read November 14, 2026); Canada Life: Workplace benefits, prior-authorization forms (read November 14, 2026); Canada Life: Drug Prior Authorization Form, semaglutide (Ozempic and generics), M6453(Ozempic)-10/26 (read November 14, 2026); Canada Life: Drug Prior Authorization Form, Wegovy (semaglutide), M6453(Wegovy)-8/26 (read November 14, 2026)

Getting a prescription online in Manitoba

Each of these drugs needs a prescription: Health Canada's Drug Product Database puts Ozempic, Wegovy, Mounjaro, Zepbound and Apo-Semaglutide in its Prescription schedule. If you don't have a prescriber, our guides list the online providers that serve Manitoba, what they charge and where to fill the prescription.

Sources: Health Canada Drug Product Database: Ozempic, DIN 02471469 (semaglutide; Schedule: Prescription, Schedule D) (read November 11, 2026); Health Canada Drug Product Database: Wegovy, DIN 02528525 (semaglutide; Schedule: Prescription, Schedule D) (read November 11, 2026); Health Canada Drug Product Database: Mounjaro KwikPen, DIN 02551950 (tirzepatide; Schedule: Prescription) (read November 11, 2026); Health Canada Drug Product Database: Zepbound, DIN 02557509 (tirzepatide; Schedule: Prescription) (read November 11, 2026); Health Canada Drug Product Database: Apo-Semaglutide Injection, DIN 02568012 (semaglutide; Schedule: Prescription) (read November 11, 2026)

Where are you in your GLP-1 journey?

Answer a few quick questions — get your cheapest path to a GLP-1 prescription, free.

Frequently asked questions

Does Manitoba Pharmacare cover Ozempic?

Through Exception Drug Status only. When we read Manitoba's EDS list on November 14, 2026 (list dated November 1, 2026), the three Ozempic pens (DINs 02471469, 02471477 and 02540258) were on it, with the criteria Manitoba publishes. Your prescriber applies by mail or fax before the prescription is filled, and once the request is approved Pharmacare pays after your deductible is met.

Sources: Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026); Manitoba: About the Manitoba Pharmacare Program (read November 14, 2026)

Is generic Ozempic covered in Manitoba?

On the same terms as Ozempic. Apotex's Apo-Semaglutide Injection and Dr. Reddy's Semaglutide Injection are on the EDS list, and Pharmacare reimburses an interchangeable drug only up to the lowest price in its category.

Sources: Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026); Manitoba Drug Interchangeability Formulary, 152nd edition, effective November 1, 2026 (read November 14, 2026); Manitoba Drug Benefits and Interchangeability Formulary (editions effective November 1, 2026) (read November 14, 2026)

Is Mounjaro covered in Manitoba?

Not by Manitoba Pharmacare. The Drug Formulary Lookup finds no Mounjaro or tirzepatide, and the EDS list has no tirzepatide product. You pay the pharmacy price unless a private plan covers it.

Sources: Manitoba Drug Formulary Lookup: searches for Ozempic, semaglutide, Mounjaro, tirzepatide, Wegovy, Zepbound, Rybelsus, Saxenda and liraglutide (read November 14, 2026); Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026)

How much is Ozempic in Manitoba without insurance?

The lowest Ozempic price we list in Manitoba is $222 at Costco Pharmacy (0.25mg/0.5mL pen, 1 pen, updated November 2026). A pharmacy may add a dispensing fee. Every pharmacy's price is on Ozempic prices in Manitoba.

Is Wegovy or Zepbound covered by Manitoba Pharmacare?
Is Ozempic free under the Manitoba Enhanced Pharmacare Program?

No. The MEPP drug list (dated November 1, 2026) has no semaglutide product, and Manitoba's MEPP page says "Ozempic was not included in the federal list of medications for no-cost coverage for discussion with provinces and territories." Ozempic stays an Exception Drug Status drug under regular Pharmacare, with its deductible.

Sources: Manitoba Enhanced Pharmacare Program Drug List (dated November 1, 2026) (read November 14, 2026); Manitoba Enhanced Pharmacare Program (MEPP) (read November 14, 2026); Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026)

Do I have to renew Exception Drug Status for Ozempic?

Yes. Some EDS approvals are indefinite, and semaglutide is not on Manitoba's list of those drugs (dated November 5, 2025), so an approval has an expiry date. Manitoba asks for the renewal request before the expiry date.

Sources: Manitoba: List of Designated Drugs with Indefinite Exception Drug Status Approval (dated November 5, 2025) (read November 14, 2026); Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026)

Sources

  1. Manitoba: About the Manitoba Pharmacare Program (read November 14, 2026): Pharmacare is "a drug benefit program for eligible Manitobans" whose income is seriously affected by high prescription drug costs. Coverage is based on your total family income and what you pay for eligible prescription drugs; each year you pay a portion, your annual Pharmacare deductible, set from your adjusted family income. You qualify if you are eligible for Manitoba Health coverage and your prescriptions are not covered by other provincial or federal programs.
  2. Manitoba Drug Benefits and Interchangeability Formulary (editions effective November 1, 2026) (read November 14, 2026): Part 1 drugs are benefits "under all prescribed circumstances", Part 2 drugs only for the terms and conditions the Formulary sets; when a drug is not in Part 1 or Part 2, "a request for coverage may be considered under Exception Drug Status (EDS)" for each person's circumstances, on the doctor's application, and the person is told the decision in writing. "Manitoba Pharmacare will reimburse only up to the lowest price in an interchangeable category for those interchangeable drugs which are Pharmacare benefits."
  3. Manitoba: Exception Drug Status (EDS) list (dated November 1, 2026) (read November 14, 2026): Page 1: an approved EDS drug is covered through the Pharmacare program for the period EDS authorizes "and after the client's Pharmacare deductible has been met". Page 2: practitioners apply by mail or fax; approval "must take place prior to purchase or dispensing" and "Retroactive coverage is not provided"; patients are notified by letter; coverage is valid "from the date of application to date of expiration", and renewal requests go in before the expiry date; "If denied, payment for the medication is the responsibility of the patient"; "Not all medications currently available on the market in Canada are benefits"; some private insurers require EDS approval before they pay. Page 31: Ozempic (DINs 02471469, 02471477 and 02540258), Apo-Semaglutide Injection (02568020 and 02568012) and Dr. Reddy's Semaglutide Injection (02567806 and 02567814), with their published criteria. No tirzepatide, Wegovy, Rybelsus or Saxenda product.
  4. Manitoba Drug Formulary Lookup: searches for Ozempic, semaglutide, Mounjaro, tirzepatide, Wegovy, Zepbound, Rybelsus, Saxenda and liraglutide (read November 14, 2026): Each search returns "No results were found that matched your search criteria", with the note that the drug "is not a Part 1 or Part 2 Pharmacare Drug Formulary Benefit" and may be a Part 3 (Exception Drug Status) benefit.
  5. Manitoba Enhanced Pharmacare Program Drug List (dated November 1, 2026) (read November 14, 2026): No semaglutide, tirzepatide or liraglutide product.
  6. Manitoba: List of Designated Drugs with Indefinite Exception Drug Status Approval (dated November 5, 2025) (read November 14, 2026): Semaglutide is not on the list.
  7. Manitoba Enhanced Pharmacare Program (MEPP) (read November 14, 2026): Since April 15, 2025, no-cost coverage of most medications in the categories the program lists, for people with an active Manitoba Health card; Pharmacare deductibles do not apply to it. On why Ozempic (semaglutide) is not covered at no cost under MEPP: "Ozempic was not included in the federal list of medications for no-cost coverage for discussion with provinces and territories."
  8. Manitoba Drug Interchangeability Formulary, 152nd edition, effective November 1, 2026 (read November 14, 2026): Page 98: three semaglutide interchangeable categories, each with an Ozempic pen and the matching Apotex or Dr. Reddy's pens.
  9. Sun Life: Prior Authorization Form, OZEMPIC (semaglutide) or generic products, 4233-PA-OZE-E-09-26 (read November 14, 2026)
  10. Sun Life: report for plan sponsors on drug management strategies (November 2025) (read November 14, 2026): Page 6 lists the five drugs of the category, Saxenda, Wegovy and Zepbound among them; page 9 has the optional category, its two strategies and Ozempic’s prior authorization.
  11. Canada Life: Workplace benefits, prior-authorization forms (read November 14, 2026): The list of forms: Ozempic and generics, Plosbrio, Poviztra, Rybelsus, Wegovy, Mounjaro and Zepbound; no Saxenda form.
  12. Canada Life: Drug Prior Authorization Form, semaglutide (Ozempic and generics), M6453(Ozempic)-10/26 (read November 14, 2026)
  13. Canada Life: Drug Prior Authorization Form, Wegovy (semaglutide), M6453(Wegovy)-8/26 (read November 14, 2026)
  14. Health Canada Drug Product Database: Ozempic, DIN 02471469 (semaglutide; Schedule: Prescription, Schedule D) (read November 11, 2026)
  15. Health Canada Drug Product Database: Wegovy, DIN 02528525 (semaglutide; Schedule: Prescription, Schedule D) (read November 11, 2026)
  16. Health Canada Drug Product Database: Mounjaro KwikPen, DIN 02551950 (tirzepatide; Schedule: Prescription) (read November 11, 2026)
  17. Health Canada Drug Product Database: Zepbound, DIN 02557509 (tirzepatide; Schedule: Prescription) (read November 11, 2026)
  18. Health Canada Drug Product Database: Apo-Semaglutide Injection, DIN 02568012 (semaglutide; Schedule: Prescription) (read November 11, 2026)
  19. Sun Life: optional drug category, prior authorization from October 15, 2024 (August 13, 2024) (read October 2, 2026): Read via the Wayback snapshot of 2026-06-09.
  20. Canada Life: Wegovy prior authorization form M6453 ("not covered under all benefit plans") (read October 2, 2026)

Health Canada compliance: GLP1Prices.ca displays drug names, prices, and quantities only. We do not make therapeutic claims. This website does not provide medical advice. Consult your healthcare provider about medication options.

Related

Update log

  • New page: what Manitoba Pharmacare pays for Ozempic, generic semaglutide, Mounjaro, Wegovy and Zepbound, from Manitoba's Exception Drug Status list, Drug Formulary Lookup and Enhanced Pharmacare list, with cash prices and prescription options.
Check your insurance coverage